article thumbnail

Richard M. Johnson Celebrated for Dedication to the Pharmaceuticals Industry

The Pharma Data

He previously helped build pharmaceutical manufacturing sites across the world, including a plant in China in the 1980s. HARRIMAN, TN, October 23, 2020 /24-7PressRelease/ — Richard M. He previously helped build pharmaceutical manufacturing sites across the world, including a plant in China in the 1980s.

article thumbnail

Forging a Path Forward for Substance Abuse Potential Studies With the Cross-Company Abuse Liability Council By Beatrice Setnik, PhD

Alta Sciences

The CCALC is a grassroots organization that was founded by several pharmaceutical industry members seeking clarity around the conduct of abuse and dependence potential assessments for novel drugs in development. This was in 2006, at a time when the FDA guidances on these topics had not yet been published.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Speaking of Medicine – Mid-Year OPDP Enforcement Review

Eye on FDA

There are two means of gaining insight into the agency’s thinking about regulatory issues related to promotional communications by pharmaceutical companies; one is through the issuance of guidance documents, the other is through enforcement. But when it comes to enforcement things have changed greatly over the years.

article thumbnail

AI in gene delivery vector discovery and design

Drug Target Review

Many biotechnology start-ups, leveraging AI and high-throughput experiments, play a pivotal role in revolutionising gene therapy, while some traditional pharmaceutical giants have also displayed strong interest in this AI-driven AAV design approach. Journal of virology 82 , 5887-5911 (2008). Grimm D, et al.

article thumbnail

How the AI revolution can accelerate early drug discovery

Drug Target Review

Training AI/ML tools to predict results of otherwise complex and time-consuming calculations is gaining traction in pharmaceutical R&D. To really benefit from AI, the pharmaceutical industry must be more open to data sharing. Research and Development in the Pharmaceutical Industry | Congressional Budget Office [Internet].

Drugs 105
article thumbnail

Advanced 3D cell-based technologies

Drug Target Review

The International Consortium for Innovation and Quality in Pharmaceutical Development has published guidelines to qualify as a valid model for specific organ-chip applications. The first successful chip adaptation to a lung model was first described in 2010 by Donald Ingber, a bioengineer at Wyss institute.

article thumbnail

Gianluca Pirozzi, MD, PhD, Celebrated for Dedication to the Field of Immunology and Rare Disease Research

The Pharma Data

Pirozzi now serves as Senior Vice President, Head of Clinical Development and Translational Sciences at Alexion Pharmaceuticals, Inc., positions he assumed in 2020. At Alexion, he is responsible for the development of medicines for rare and devastating diseases in hematology, nephrology, neurology, ophthalmology, and for metabolic syndromes.

Disease 52